Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of linperlisib in relapsed or refractory thymic carcinoma
CTR20211436Phase 2Active
- Sponsor
- Yingli Pharma
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in thymic carcinoma (TC), sponsored by Yingli Pharma. Started Jul 2021; status: active.
02
Drugs
linperlisib
03
Conditions
thymic carcinoma (TC)
Beyond the preview
Go deeper on CTR20211436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211436.